CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Jun 29, 2026

Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
99.3%
-0.3% vs 52w high · +12.2% 1mo

Price (last ~year)

CVS Health Corp reported $100.43 billion in revenue for the quarter ending March 31, 2026, contributing to a 63.1% year-over-year increase in earnings. The stock is trading at $104.34, reflecting a 46.5% gain over the last three months and placing the price at 99.3% of its 52-week high. While the company has exceeded earnings estimates for four consecutive quarters, it continues to navigate regulatory scrutiny regarding pharmacy benefit managers and a recent downgrade to hold by Wall Street Zen.

Valuation

Market cap
$133.13B
P/E
45.56
PEG
0.294
P/B
1.719
P/S
0.328
EV/EBITDA
17.94
Beta
0.623
Analyst target
$105.38

Quality & returns

Gross margin
13.4%
Operating margin
4.1%
Profit margin
0.7%
ROE
3.8%
ROA
2.7%

Price movement

Last
$104.34
1-month
+12.2%
3-month
+46.5%
RSI (14)
76
vs SMA200
+30.3%
52-wk position
99.3% -0.3% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B
2025-06-30$98.92B$2.38B$1.02B$3.58B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots